Matches in Nanopublications for { ?s ?p "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.
- assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1092621.RAXLtWAcNM41n6I6nTnGegtQdwuEU7K-9jX19Ccgimpqw130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092621.RAXLtWAcNM41n6I6nTnGegtQdwuEU7K-9jX19Ccgimpqw130_provenance.
- NP1092618.RAmlAqg7mTpqvywvnYOYSzjFEKNGHYfjQCMpWiaeZKPws130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092618.RAmlAqg7mTpqvywvnYOYSzjFEKNGHYfjQCMpWiaeZKPws130_provenance.
- NP747025.RA03WEvvOWfUVs5QFwWPfYhwsxI6MEM9Ws0-Uj3q_IHAc130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747025.RA03WEvvOWfUVs5QFwWPfYhwsxI6MEM9Ws0-Uj3q_IHAc130_provenance.
- NP820320.RA-oLwiIuwk61graMOym8w1m0iP8WZcnxeFZIZ-t0VqRQ130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820320.RA-oLwiIuwk61graMOym8w1m0iP8WZcnxeFZIZ-t0VqRQ130_provenance.